Curis, Inc. (CRIS): Price and Financial Metrics

CRIS POWR Grades

• CRIS scores best on the Sentiment dimension, with a Sentiment rank ahead of 86.03% of US stocks.
• The strongest trend for CRIS is in Growth, which has been heading down over the past 177 days.
• CRIS ranks lowest in Momentum; there it ranks in the 4th percentile.

CRIS Stock Summary

• For CRIS, its debt to operating expenses ratio is greater than that reported by only 10.67% of US equities we're observing.
• With a year-over-year growth in debt of -26.38%, CURIS INC's debt growth rate surpasses only 12.41% of about US stocks.
• In terms of volatility of its share price, CRIS is more volatile than 99.39% of stocks we're observing.
• If you're looking for stocks that are quantitatively similar to CURIS INC, a group of peers worth examining would be BCDA, ALGS, RXRX, TSP, and GSIT.
• Visit CRIS's SEC page to see the company's official filings. To visit the company's web site, go to www.curis.com.

CRIS Valuation Summary

• CRIS's price/sales ratio is 4.9; this is 164.86% higher than that of the median Healthcare stock.
• CRIS's price/sales ratio has moved down 2.5 over the prior 243 months.

Below are key valuation metrics over time for CRIS.

CRIS Growth Metrics

Its 3 year net cashflow from operations growth rate is now at -34.36%.
• Its 2 year cash and equivalents growth rate is now at 36.79%.
• Its 5 year cash and equivalents growth rate is now at -68.17%.

Over the past 33 months, CRIS's revenue has gone up $406,000.

The table below shows CRIS's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	10.41	-50.24	-58.963
2022-06-30	10.624	-46.728	-56.72
2022-03-31	10.517	-41.255	-51.618
2021-12-31	10.649	-37.619	-45.436
2021-09-30	10.538	-35.163	-39.333
2021-06-30	10.241	-31.43	-34.256

CRIS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CRIS has a Quality Grade of C, ranking ahead of 36.2% of graded US stocks.
• CRIS's asset turnover comes in at 0.066 -- ranking 302nd of 682 Pharmaceutical Products stocks.
• YMTX, VTRS, and KDNY are the stocks whose asset turnover ratios are most correlated with CRIS.

The table below shows CRIS's key quality metrics over time.